期刊文献+

伊布利特与胺碘酮对阵发性房颤复律的疗效比较 被引量:5

Comparison of Clinical Effect of ibutilide vs Amiodarone on Cardioversion of Paroxysmal Atrial Fibrillation
下载PDF
导出
摘要 [目的]研究Ⅲ类抗心律失常药物依布利特与胺碘酮转复阵发性心房颤动(房颤) 的有效性及安全性.[方法]入选阵发性房颤患者63例(男32例,女31例),随机进入依布利特组(n=28)、胺碘酮组(n=35).前者于10 min内静脉注射依布利特1 mg,如给药结束10 min后仍未转复为窦性心律, 重复前述治疗1次.后者于10 min内静脉注射胺碘酮150 mg,后以1 mg/min维持6 h,再以0.5 mg/min维持18 h,转复后即刻停药.观察给药后房颤的转复率、转复时间、心室率、QTc变化及不良反应.[结果] 依布利特组转复率明显高于胺碘酮组(67.9% vs 40.0%,P=0.028),转复时间明显短于胺碘酮组[(20.11±11.54) min vs (523.31±277.73) min,P=0.000];伊布利特组10 min、30 min时对心室率和QTc影响大于胺碘酮组(P〈0.05).胺碘酮组有2例出现轻度低血压,1例胃肠炎,伊布利特组出现2例单形室性心动过速,两组患者不良反应率差异无统计学意义(P〉0.05).[结论] 伊布利特转复阵发性房颤疗效高于胺碘酮,转复时间短,是一种转复房颤快速、有效的药物,但用药前后必须加强心电监护. [Objective]To compare the efficacy and safety of class III antiarrhythmic drugs ibutilide vs amiodarone for the cardioversion of paroxysmal atrial fibrillation(AF). [Methods] A total of 63 paroxysmal AF patients(32 male and 31 female) were selected and randomly divided into ibutilide group( n =28) and amiodarone group( n=35). The ibutilide group received intravenous injection of ling ibutilide within 10min, and if not reverted to sinus rhythm, above the dose repeated. The amiodarone group received intravenous injection of 150mg amiodarone within 10min followed by a dose of lmg/min maintained for 6h, then 0. 5mg/min maintained for 18h. After eadioversion achieved, the drug was stopped immediately. The suceessful rate of cardioversion, cardioversion time, heart rate, the changes of QTc and adverse reactions were observed. [Results] The cardioversion rate of the ibutilide group was significantly higher than that of the amiodarone group(67.90% vs 40.0%, P =0. 028). The cardioversion time in ibutilide group was shorter than that in amiodarone group (20.11±11.54min vs 523.31±277.73min, P=0. 000). The influence on heart rate and QTc in the ibutilide group was greater than that in the amiodarone group at 10min and 30rain( P d0.05). In amiodarone group, 2 patients had transient hypotension and 1 had gastroenteritis. In ibutilide group, monomorphic ventricular tachyeardia was found in 2 patients. There was no statistical difference in the rate of adverse reactions between two groups( P 〉0.05). [Conclusion] Ibutilide for the eardioversion of paroxysmal atrial fibrillation is more effective than amiodarone. It is a rapid and effective medicine of cardioverion. However, strict cardiac monitoring should be strengthened before and after taking medicine.
出处 《医学临床研究》 CAS 2010年第10期1801-1803,共3页 Journal of Clinical Research
基金 广东省科技计划项目(20088030301142)
关键词 心房颤动/药物疗法 胺碘酮/治疗应用 atrial fibrillation/DT amiodarone/TU
  • 相关文献

参考文献9

  • 1Levy S,Breithardt G,Cmapbell RW,et al.Atrial fibrillation:cuerrnt knowledge and recommendations of management:Working Group on Arrhythmias of the European Society of Cardiology[J].Eur Heart J,1998,19(9):1294-1320.
  • 2郭继鸿.心房颤动药物治疗的10个临床问题[J].中国实用内科杂志,2008,28(6):422-425. 被引量:38
  • 3Lip G Y,Tello-Montoliu A.Management of atrial fibrillation[J].Heart,2006,92 (8):1177-1182.
  • 4Oshikawa N,Watanabe I,Masaki R,et al.Frequency-dependent electrophysiologial effect of ibutilide on human atrium and ventricle[J].J Interv Card Electrophysiol,2001,5(1):81-87.
  • 5Lee K S,Lee E W.Ionic mechanism of ibutilide in human atrium:Evidence for a drug-induced Na+ current through a nifedipine inhibited inward channel[J].J Pharmacol Exp Ther,1998,286(1):9-22.
  • 6Baskin EP,Lynch JJ.Differential atrial versus ventricular activities of class Ⅲ potassium channel blockers[J].J Phamacol Exp Ther,1998,285(1):135-142.
  • 7张楠,郭继鸿,张海澄,孙健玲,陈冰,游红.依布利特与普罗帕酮转复心房颤动的临床研究[J].中华心律失常学杂志,2005,9(1):29-33. 被引量:13
  • 8Nikolaos V,Kafkas,Sotirios P,Patsilinakos,George A.Mertzanos.Conversion efficacy of intravenous ibutilide compared with intravenous amiodarone in patients with recent-onset atrial fibrillation and atrial flutter[J].Int J Cardiol,2007,118(3):321-325.
  • 9Gowdw RM,Punukollu G,Khan LA,et al.Ibutilide for pharmacological cardioversion of atrial fibrillation and flutter:impact of race on efficacy and satety[J].Am J Ther,2003,10(4):269-263.

二级参考文献20

  • 1Naccarelli GV,Lee KS,Gibson JK,et al.Electrophysiology and pharmacology of ibutilide.Am J Cardiol,1996,78:12-16.
  • 2Lych JR,Baskin EP,Nutt EM,et al.Comparison of binding to rapidly activating delayed rectifier K channel,Ikr and effects on myocardial refractoriness for class Ⅲ antiarrythmic agents.J Cardiovasc Pharmacol,1995,25:336-340.
  • 3Baskin EP,Lynch JJ Jr.Differential atrial versus ventricular activities of class Ⅲ potassium channel blockers.Pharmacol Exp Ther,1998,285:135-142.
  • 4Stambler BS,Beckman KJ,Kardish AH,et al.Acute hemodynamic effects of intravenous Ibutilide in patients with or without reduced left ventricular function.Am J Cardiol,1997,80:458- 463.
  • 5Stambler BS,Wood MA,Ellenbogen KA,et al.Antiarrhymic actions of intravenous Ibutilide compared with procaimamide during human atrial flutter and fibrillation:electrophysilogical determinants of enhanced conversion efficacy.Circulation,1997,96,4298- 4306.
  • 6Volgman AS,Stambler BS,Kappagoda C,et al.Comparison of intravenous Ibutilide versus procainainamide for rapid termination of atrial flutter or fibrillation.PACE,1996,19:608.
  • 7Kannel WB,Abbott RD,Savage DD,et al.Epidemiologic features of chronic atrial fibrillation:the Framingham study.N Engl J Med,1982,306:1018-1022.
  • 8Wijffels MECF,Kirchof CJHJ,Dorland R,et al.Atrial fibrillation begets atrial fibrillation.A study in awake chronically instrumented goats.Circulation,1995,92:1954-1968.
  • 9Cropp JS,Antal EG,Talbert RL,et al.Ibutilide:a new class Ⅲ antiarrhythmic agent.Parmarcotherapy,1997,17:1-9.
  • 10Vos MA,Golitsyn SR,Stangl K,et al.Superiority of ibutilide (a new class Ⅲ agent) over DL-sotalol in converting atrial flutter and atrial fibrillation.Heart,1998,79:568-575.

共引文献49

同被引文献54

  • 1Panagiotis Korantzopoulos,Konstantinos P Letsas,Anna Kotsia,Giannis Baltogiannis,Kallirroi Kalantzi,Konstantinos Kyrlas,John A Goudevenos.Ibutilide and novel indexes of ventricular repolarization in persistent atrial fibrillation patients[J].World Journal of Cardiology,2013,5(7):242-246. 被引量:3
  • 2周自强,胡大一,陈捷,张仁汉,李奎宝,赵秀丽.中国心房颤动现状的流行病学研究[J].中华内科杂志,2004,43(7):491-494. 被引量:1401
  • 3孙健玲,郭继鸿,刘鹏,张萍,易忠,刘刚,刘斌.伊布利特对犬心脏电生理特性的影响[J].中国心脏起搏与心电生理杂志,2005,19(4):284-287. 被引量:10
  • 4杨敏,廖德宁,张家友,顾兴建,杜荣增,赵伟,赵学,吴宗贵.伊布利特转复心房颤动/心房扑动的临床观察[J].中华心律失常学杂志,2005,9(4):291-294. 被引量:16
  • 5Andrs RPR,Augusto HU,Celso F,et al.Relationship among amiod-arone,new class III antiarrhythmics,miscellaneous agents and ac-quired long QT syndrome. Cardiology Journal . 2008
  • 6Viktorsdottir O,Henriksdottir A,Arnar DO.Ibutilide for treatment ofatrial fibrillation in the emergencydepartment. EmergMed J . 2006
  • 7Warm LS,Curtis AB,Ellenbogen KA. 201l ACCF/AHA/HRS focused update on the management of patients Wim Atrial Fibrillation (Update on Dabigatran)[J].Circulation,2011,(10):1144-1150.
  • 8Kafkas NV,Patsilinakos SP,Mentzanos GA. Conversion efficacy of intravenous ibutilide compared with intravenous amiodarone in patients with recent-onset atrial fibrillation and atrial flutter[J].International Journal of Cardiology,2007,(03):321-325.doi:10.1016/j.ijcard.2006.07.017.
  • 9Martinez-Marcos FJ,Garcia-Garmendia JL,Ortega-Carpio A. Comparison of intravenous flecainide,propafenone,and amiodarone for conversion of acute atrial fibrillation to sinus rhythm[J].American Journal of Cardiology,2000,(09):950-953.
  • 10Singh BN,Singh SN,Reda DJ. Amiodarone versus sotalol for atrial fibrillation[J].New England Journal of Medicine,2005,(18):1861-1872.

引证文献5

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部